Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma
暂无分享,去创建一个
K. Black | W. Streit | T. Baba | T. Morioka
[1] W. Streit,et al. Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia , 2004, Acta Neuropathologica.
[2] H. Budka,et al. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation , 2004, Acta Neuropathologica.
[3] M. Esiri,et al. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas , 2004, Acta Neuropathologica.
[4] M. Esiri,et al. Immunohistological study of mononuclear cell infiltrate in malignant gliomas , 2004, Acta Neuropathologica.
[5] K. Black,et al. Response of microglial cells to experimental rat glioma , 1992, Glia.
[6] W. Streit,et al. Expression of immunomolecules on microglial cells following neonatal sciatic nerve axotomy , 1991, Journal of Neuroimmunology.
[7] P. Albert,et al. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. , 1991, Journal of immunology.
[8] M. Esiri,et al. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease 2. Non-neoplastic diseases , 1991, Journal of the Neurological Sciences.
[9] M. Esiri,et al. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease 1. Gliomas , 1991, Journal of the Neurological Sciences.
[10] J. Merrill,et al. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFβ , 1991, Glia.
[11] T. Mapstone,et al. Expression of platelet-derived growth factors, transforming growth factors, and the ros gene in a variety of primary human brain tumors. , 1991, Neurosurgery.
[12] M. Graeber,et al. Microglia: Immune Network in the CNS , 1990, Brain pathology.
[13] M. Graeber,et al. New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury , 1990, Journal of Neuroimmunology.
[14] H. Schluesener. Transforming growth factors type β 1 and β 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-γ and tumor necrosis factor-α , 1990, Journal of Neuroimmunology.
[15] H. Schluesener. Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha. , 1990, Journal of neuroimmunology.
[16] K. Frei,et al. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. , 1989, Journal of immunology.
[17] M. Graeber,et al. Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury , 1989, Experimental Neurology.
[18] M. Turner,et al. Modulation of cytokine production by transforming growth factor-beta. , 1989, Journal of immunology.
[19] M. Graeber,et al. Identity of ED2‐positive perivascular cells in rat brain , 1989, Journal of neuroscience research.
[20] M. Graeber,et al. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells , 1988, Journal of neuroscience research.
[21] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-β , 1988, Nature.
[22] J. Bressler,et al. Transforming growth factor-β-like activity in tumors of the central nervous system , 1988 .
[23] C. Morris,et al. Mononuclear cell infiltration in central portions of human astrocytomas. , 1988, Journal of neurosurgery.
[24] S. Miescher,et al. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. , 1988, Journal of neurosurgery.
[25] W. Roggendorf,et al. Inflammatory infiltrates and natural killer cell presence in human brain tumors , 1988, Cancer.
[26] C C Chang,et al. Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. , 1988, Journal of neurosurgery.
[27] J. Bressler,et al. Transforming growth factor-beta-like activity in tumors of the central nervous system. , 1988, Journal of neurosurgery.
[28] T. Espevik,et al. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha , 1987, The Journal of experimental medicine.
[29] W. Jefferies,et al. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[30] K. Frei,et al. Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .
[31] D. Giulian. Ameboid microglia as effectors of inflammation in the central nervous system , 1987, Journal of neuroscience research.
[32] M. Esiri,et al. Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. , 1986, Journal of clinical pathology.
[33] D. Mason,et al. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. , 1986, Immunology.
[34] H. Handa,et al. Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors. , 1986, Neurosurgery.
[35] E. Döpp,et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Immunology.
[36] A. Barclay,et al. Molecular and antigenic heterogeneity of the rat leukocyte‐common antigen from thymocytes and T and B lymphocytes , 1985, European journal of immunology.
[37] M. Apuzzo,et al. Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. , 1984, Journal of neurosurgery.
[38] Alan F. Williams,et al. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus , 1982, European journal of immunology.
[39] W. McMaster,et al. Two subsets of rat T lymphocytes defined with monoclonal antibodies , 1980, European journal of immunology.
[40] W. McMaster,et al. Identification of Ia glycoproteins in rat thymus and purification from rat spleen , 1979, European journal of immunology.
[41] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.
[42] H. Rodt,et al. Immunofluorescence study of lymphocytic infiltration in gliomas Identification of T-lymphocytes , 1977, Journal of the Neurological Sciences.
[43] R. Barnard,et al. Perivascular lymphocytic cuffing in astrocytomas. , 1976, Acta neuropathologica.